NAPROXEN Detail

Drug Name(s):
NAPROXEN

FDA Application No.:
NDA 075227

Active Ingredient(s):
NAPROXEN

Company:
TEVA

Original Approval or Tentative Approval Date:
June 29, 1998

Products on Application NDA 075227:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
NAPROXEN	500MG	TABLET, DELAYED RELEASE; ORAL	Prescription	AB

Recall Notices

Celeste Industries Corporation Recalls All Lots of simplySmart Remove Make Up Remover (January 5)
National Brands Inc. Issues a Nationwide Recall of Topaz brand Wafer Rolls Because of Possible Health Risks (December 19)
FDA Announces Class I Recall of Ophthalmic Surgical Device
Stryker Craniomaxillofacial Issues Nationwide Recall of its Custom Cranial Implant Kits; Catalogue Numbers 54-00101, 54-00102, 54-00103 and 54-00104, all lots shipped sterile (December 23)
KRC Food Trading Inc. Recall of Fish Cake Sushi (December 23)

Action Alerts

Alerts do not necessarily reflect the opinion of Medicine.org

Active forum topics

Poll

email this page | older polls | results

Subscribe to our feed

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

January 2009

NAPROXEN Detail

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed

Welcome

Diseases & Conditions

Navigation

Resources

Medical Dictionary

Drug Information

Events

Who's online

Job search